2025, Volume 3, Issue 1
2025, Volume 3, Issue 1
March 2025
DRD vs. D-VCD in Newly Diagnosed AL Amyloidosis: A Retrospective Single-Center Study
Larisa ZIDARU, Andreea JERCAN, Sinziana BARBU, Daniel Nicolae MURARIU, Daniel CORIU, Sorina Nicoleta BADELITA
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.5
17p13.1 Deletion in Small B-cell Lymphocytic Lymphomas: A Prognostic Factor and Diagnostic Approach
Andreea-Georgiana STOICA, Miruna CRISTIAN, Mariana ASCHIE, Anca-Florentina MITROI, Georgiana-Camelia COZARU, Gabriela-Izabela BALTATESCU, Mădălina BOSOTEANU, Mihaela-Maria GHINEA
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.11
Antiphospholipid Antibodies in Non-Hodgkin's Lymphoma
Sanda BURUIANA, Maria ROBU, Victor TOMACINSCHII, Minodora MAZUR, Lucia MAZUR-NICORICI
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.19
Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question
Catalina GURAN, Mieta-Gabriela HATEGAN, Dacian Nicolae OROS, Despina CALAMAR-POPOVICI, Marioara IONITA HORTENSIA, Claudiu IONITA, Florica GHILEZAN, Ioana IONITA
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.29
Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera
Diana GRASU, Viola Maria POPOV, Mirela VOICU, Mihaela POPESCU, Oana PATRINOIU, Felicia MIHAI, Geanina OFITERU, Meilin OMER, Mihaela ANDREESCU
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.39
Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP)
Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU
2025 Vol. 3 Nr. 1
https://doi.org/10.59854/dhrrh.2025.3.1.49